£112.19

Academic Press Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 5 months ago.

£112 today · all-time low £111 (Jan 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical
Generating forecast...
£116.29 £110.79 £111.99 £113.19 £114.39 £115.59 £116.79 09 June 2024 15 November 2024 23 April 2025 29 September 2025 07 March 2026

Price Distribution

Price distribution over 637 days • 5 price levels

Days at Price
Current Price
217 days · current 59 days 104 days 212 days 45 days 0 54 109 163 217 £112 £113 £114 £115 £116 Days at Price

Price Analysis

Most common price: £112 (217 days, 34.1%)

Price range: £112 - £116

Price levels: 5 different prices over 637 days

Description

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. The book discusses topics such as molecular mechanisms of chemoresistance, experimental models to study chemoresistance, chemoresistance to drugs other than Temozolomide, and specific strategies to reverse chemoresistance. Additionally, it encompasses information on how to mitigate chemoresistance by targeted enhancement of p53 function. This book is a valuable resource for cancer researchers, oncologists, neuro-oncologists and other members of the biomedical field. Glioblastoma (GBM) is the most invasive and malignant primary brain tumor in humans with poor survival after diagnosis, therefore it is imperative that molecular and cellular mechanisms behind therapy resistant GBM cells, as well as the therapeutic strategies available to counter the resistance are comprehensively understood. Review Presents the most relevant information on the basic science, pre-clinical research, and clinical management of glioblastoma chemoresistance From the Back Cover Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. Glioblastoma (GBM) is the most invasive and malignant primary brain tumor in humans with poor survival after diagnosis, therefore it is imperative that molecular and cellular mechanisms behind therapy resistant GBM cells, as well as the therapeutic strategies available to counter the resistance are understood comprehensively. The book discusses topics such as molecular mechanisms of chemoresistance, experimental models to study chemoresistance, chemoresistance to drugs other than Temozolomide, and specific strategies to reverse chemoresistance. Additionally, it encompasses information on how to mitigate chemoresistance by targeted enhancement of p53 function. This book is a valuable resource for cancer researchers, oncologists, neuro-oncologists and several members of biomedical field who are interested in understanding the current strategies to fight chemoresistance in glioblastomas. About the Author Dr. Paulmurugan has expertise in molecular imaging, pre-clinical cancer imaging, cancer biology, nanotechnology, and molecular biotechnology. Dr. Massoud has expertise in molecular imaging, translational cancer imaging, neuro-oncology, and applications and perspectives relevant to clinical cancer management of glioblastoma patients.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Glioblastoma
98% match

Glioblastoma

Elsevier

£75.29 08 Jan 2026
New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics
98% match

New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics

£117.69 13 Jan 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£117.56 12 Jan 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£147.91 10 Mar 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
97% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£141.86 16 Apr 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.13 06 Feb 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.73 05 Feb 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
97% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£147.07 12 Jan 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£124.65 30 Mar 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
97% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

£67.04 12 Jan 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
97% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

Springer

£76.81 05 Mar 2026
Glioblastoma
97% match

Glioblastoma

MDPI AG

£95.47 07 Mar 2026
New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)
97% match

New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)

Academic Press

£110.99 01 Mar 2026
Springer Molecular Pathology of Nervous System Tumors Book
97% match

Springer Molecular Pathology of Nervous System Tumors Book

Springer

£107.53 27 Feb 2026
MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)
97% match

MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)

£166.00 10 Mar 2026
Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)
97% match

Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)

Springer

£119.87 27 Feb 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
97% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 16 Mar 2026
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
96% match

Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches

Springer

£61.16 08 Mar 2026
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
96% match

Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches

Springer

£87.30 07 Mar 2026
Glioma: Immunotherapeutic Approaches: 746 (Advances in Experimental Medicine and Biology, 746)
96% match

Glioma: Immunotherapeutic Approaches: 746 (Advances in Experimental Medicine and Biology, 746)

Springer

£80.39 13 Apr 2026
Humana High-Grade Gliomas: Diagnosis and Treatment Book
96% match

Humana High-Grade Gliomas: Diagnosis and Treatment Book

Humana

£34.33 26 Feb 2026
Functional Brain Tumor Imaging
96% match

Functional Brain Tumor Imaging

Springer

£93.19 24 Feb 2026
Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)
96% match

Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)

Humana

£5.29 17 Feb 2026
High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)
96% match

High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)

Humana

£156.39 09 Mar 2026